F.D.A. Approves Cystic Fibrosis Drug
Wednesday, February 1, 2012 - 16:50
in Health & Medicine
The Food and Drug Administration called Kalydeco a “breakthrough therapy” because it treats the underlying cause of the genetic disease, rather than just the symptoms.